openPR Logo
Press release

Retinitis Pigmentosa (RP) Market Focusing on intrinsic limitations 2025

05-31-2018 07:12 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR Research

/ PR Agency: TMR Research
Retinitis Pigmentosa (RP) Market Focusing on intrinsic

Global Retinitis Pigmentosa (RP) Market: Snapshot

Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise.

Request Sample Copy of the Report @
https://www.tmrresearch.com/sample/sample?flag=B&rep_id=91

As of now, there are no specific treatments available for retinitis pigmentosa. Efficient treatments for retinitis pigmentosa are much awaited, particularly for genetically defined subsets of patients. Various studies suggest that this disease affects about 1 in 4,000 individuals worldwide. Without treatment, patients permanently lose central vision by the age of 60. For past many years, there have been several treatments reported, which did not completely cure the disease but were beneficial to some extent. For instance, in the past, patients used to consume a supplement of 15,000 I.U. of Vitamin A and possibly fish oil to address this conditions. In 2011, a method of treatment was patented, in which a medical dose of insulin, IGF-1, and chlorin e6 was used. Another treatment option which was proposed in November 2012 was a combined treatment regimen of oily fish (DHA), vitamin A palmitate, and lutein. This treatment was reported to slow vision loss in people suffering from the disease. Rare forms may also be treated with vitamin supplements or diet modification.

Looking at the immense growth potential, several new players are likely to venture into the global retinitis pigmentosa market, thereby making it a highly competitive arena in the near future.

Global Retinitis Pigmentosa (RP) Market: Overview

Retinitis Pigmentosa (RP), an inherited retinal condition causing retinal degeneration and visual field loss, is a rare disease. Its initial symptoms are reduced night vision and loss of peripheral vision. It gradually causes blindness. There is no definitive cure for retinitis pigmentosa. Therefore, the market for treating this genetic disorder is vastly untapped. The available therapies apply various approaches such as stem cell therapy and transcorneal electric stimulation therapy. However, such therapies have not been approved of unanimously on account of certain intrinsic limitations.

Request TOC of the Report @
https://www.tmrresearch.com/sample/sample?flag=T&rep_id=91

A range of services and devices are available to aid people with vision loss to conduct their day to day activities independently. Those include anything from a vision aid and an eye care professional to orientation and mobility specialists and certified low vision therapists, among others.

Global Retinitis Pigmentosa (RP) Market: Trends and Opportunities

The global retinitis pigmentosa market has been treading a healthy growth path due to limited availability of therapeutics to cure this rare disease which has opened up a window of opportunity for new therapies and treatments. In fact, most people afflicted with the genetic disorder progress to the advanced stage of retinitis pigmentosa because of the dearth of proper cure. This has generated demand for retinal prosthesis devices for restoring the lost vision. Second Sight Medical Products, Inc., for example, offers FDA approved Argus II retinal prosthesis system meant for patients with advanced retinitis pigmentosa. This device does the function of degenerated retinal cells and enhances the patient’s ability to see images and movement.

A new approach known as optogenetics, which involves applying gene therapy for restoring vision, is currently being researched upon by companies operating in the ophthalmology market. It helps to power cells, especially ganglion cells, to respond to light after the degeneration of rod cells and cone cells. Further, the orphan drug designation given by the FDA and European Commission to ReN003 by ReNeuron in the U.S. and Europe in 2013 is another positive development in the market. ReN003 is a retinal stem cell therapy candidate.

Global Retinitis Pigmentosa (RP) Market: Regional Outlook

Based on geography, the global retinitis pigmentosa market can be segmented into North America, Europe, Asia Pacific, and the Rest of the World. Among them, North America and Europe dominate the market powered by the developed markets of the U.S and U.K. where exhaustive research and development activities have been carried out in this direction. However, the Asia Pacific market is also poised for growth due to the large patient pool in the region, who need to be treated for retinitis pigmentosa. The Rest of the World also has a substantial number of people suffering from this rare genetic disorder.

Read Comprehensive Overview of Report @
https://www.tmrresearch.com/retinitis-pigmentosa-market

Companies Mentioned in Report

To present an study the current competitive dynamics in the global market for retinitis pigmentosa (RP), the report has profiled some of the major players involved in the development and commercialization of products in the field such as ReNeuron Group plc, Amarantus BioScience Holdings, Inc., Ocugen, Inc., ReGenX Biosciences, LLC, Sucampo Pharmaceuticals, Orphagen Pharmaceuticals, Inc., Inc., and Okuvision GmbH.

Global Retinitis Pigmentosa (RP) Market, by Geography

North America
Asia Pacific
Europe
Rest of the World

This report gives you access to decisive data such as:

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-1050

Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinitis Pigmentosa (RP) Market Focusing on intrinsic limitations 2025 here

News-ID: 1066551 • Views: 213

More Releases from TMR Research

Autonomous Material Handling Technologies Market Growth and Restrain Factors Ana …
Increasing acceptance of automation and autonomous technologies across manufacturing and retail sectors has been the key factor responsible for the demand growth in autonomous material handling technologies. A growing trend miniaturization of material handling equipment across industries and critically reducing time for the final throughput are further pushing adoption prospects of autonomous material handling technologies. Technical glitches and expensive capital spending may remain the longstanding challenge widespread adoption of autonomous
Indoor Positioning & RTLS Market Future Growth Analysis by 2028
Global Indoor Positioning & RTLS Market: Snapshot Today beacon enabled smartphone apps are used for positioning the assets within a facility. However, these apps are limited to inherent and precision latency. In order to resolve these issues, various players of indoor positioning & RTLS market are integrating new technologies into their proximity solutions. These solutions provide precise and fast location detection and made it easy for businesses to expand their customer
Cloud DVR Market Key Players, Latest Trends, Future Strategies And Growth Foreca …
Cloud DVR Market: Snapshot A DVR or a digital video recorder is an electronic device that has a digital storage. These devices can digitally record videos and store it. Cloud DVRs can help the user to record their favourite television programs and shows and store them through cloud service. Also, cloud DVRs can be accessed from anywhere and any device. Such factors are helping to increase the popularity of the cloud
Mobile First Video Services Market Dynamics, Supply and Demand, Growth by 2028
Global Mobile First Video Services Market: Overview Nowadays, an average consumer watches more video on their mobile phones than any other device. According to a study by Cisco, mobile video will hold more than 75% share of the overall mobile traffic by 2021. Besides, smartphones will hold a share for over 50% in the global smart devices market. With integration of virtual reality (VR) and several other technological advancements on the

All 5 Releases


More Releases for Retinitis

Retinitis Pigmentosa (Retinitis) Industry Market Expected To Grow At High Cagr D …
Overview Retinitis Pigmentosa (RP) refers to a group of diseases which cause a slow but progressive vision loss. Retinitis pigmentosa is caused by a genetic defect. Symptoms include night blindness and loss of peripheral vision. The predisposing factors include autosomal dominant inheritance, autosomal recessive inheritance and x-linked inheritance.  Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740087-retinitis-pigmentosa-retinitis-pipeline-review-h2-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2017, provides comprehensive
Retinitis Pigmentosa (RP) Market Current Competitive Dynamics by 2025
Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise. As of now, there are no specific treatments available
Retinitis Pigmentosa (RP) Market : Upcoming Demands and Growth Analysis 2025
Retinitis pigmentosa, in which patients usually lose night vision in teenage years, side vision in middle age, and central vision in later life because of steady loss of cone photoreceptor cells and rod. Measures of retinal function, such as the electroretinogram, indicate that photoreceptor function is reduced usually several years before visual-field scotomas, symptomic night blindness, or reduced visual acuity arise. As of now, there are no specific treatments available
Market Research Focuses on Retinitis Pigmentosa (Retinitis) Market Pipeline Revi …
"The Report Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2017, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape. Retinitis Pigmentosa (RP) refers to a group of diseases which cause a slow but progressive vision
Global Cytomegalovirus Retinitis Market Size, Share | MarketResearchReports.biz
Latest industry research report on: Global Cytomegalovirus Retinitis Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Cytomegalovirus (CMV) Retinitis is caused by cytomegalovirus infection, which is a herpes-type virus that affects the retina of the human eye among patients having a weak immune system that could be due to conditions such as AIDS, leukemia and/or pregnancy. Symptomatic conditions include floaters, flashes, and blind spots besides
Retinitis Pigmentosa (Retinitis) Pipeline Insight and Therapeutic Assessment Rev …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Retinitis Pigmentosa (Retinitis)-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Retinitis Pigmentosa (Retinitis). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Retinitis Pigmentosa (Retinitis) by development stage, therapy